Challenges and practice gaps affecting implementation of oncology precision medicine

Though biomarker testing is now considered standard of care for therapeutic decision making in cancer care, real-world evidence has identified several practice gaps, resulting in many patients not receiving biomarker testing results and/or matched targeted therapies.

The audience will take part in a discussion with an expert panel of two pathologists and an oncologist on the following topics:

• Challenges and practice gaps identified in precision medicine implementation
• Coordination of a multidisciplinary team to ensure optimal biomarker detection and targeted therapy utilization, leading to more favorable patient outcomes

Nikoletta Sidiropoulos, MD
Associate Professor, Department of Pathology and Laboratory Medicine
University of Vermont Medical Center

Thomas Stricker, MD, PhD
Senior Medical Director of Precision Medicine
OneOncology

Heidi Ko, DO
Medical Director, Medical Affairs
Labcorp Oncology